AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05099952 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05868109 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhaled nitric oxide (iNO)
Description: In patients randomized to the this arm, iNO will be delivered into the ventilator circuit through the endotracheal tube or tracheostomy. The dose will be 80 ppm during chest compressions and reduced to 20 ppm immediately following ROC. If the patient is enrolled following ROC, the dose will be 20 ppm. Dose modifications will occur if there is toxicity or if there is a clinical concern. The iNO or sham will be continued for 72 hours or until extubation.
Study NCT05868109 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: In patients randomized to sham, the iNO delivery device will be connected to the ventilator circuit or manual ventilation bag but flow of iNO will not be turned on. For the purposes of patient safety and to maintain blinding, the respiratory therapists (RTs) will continue checks of gas flow, flow adjustments and change iNO gas tanks at rates like routine clinical procedures on patients treated with iNO or sham.
Study NCT05272358 — intervention group
Intervention type: OTHER
Intervention: NETSARC network
Description: MDTB and/or surgery in NETSARC network
Study NCT05320263 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Contact aspiration Thrombectomy
Description: The contact aspiration approach is performed, as in standard care, using a long sheath positioned in the distal cervical vasculature using an exchange technique.~A large bore balloon guide catheter as to be placed into the cervical ICA. The microcatheter is then advanced close to the thrombus and the large-bore aspiration catheter is advanced as close to the proximal aspect of the thrombus as possible. A control superselective angiogram may be used to document the extent of occlusion and thrombus. After a 3 min waiting period, the large-bore aspiration catheter is connected to a continuous aspiration from the dedicated aspiration pump while simultaneously advancing the aspiration catheter up to the face of the thrombus. through the long sheath positioned in the cervical vasculature.
Study NCT05320263 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Stent retriever thrombectomy
Description: The technique used should be in accordance with the device IFU. A large bore access guide catheter possible is recommended. A suitable delivery microcatheter is navigated over a microwire across the occlusion. A control superselective angiogram may be used to document the extent of occlusion and thrombus. The stent is left in place according to the internal practice of each participating center before the withdrawal. Any CE-marked stent retriever device is then deployed across the occlusion. A minimum of 3 attempts with SR should be performed. A revascularization score will be recorded after each device attempt.
Study NCT06120985 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Countertop pitcher water filter
Description: Point-of-use drinking water filter
Study NCT05505955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-5965
Description: Subjects took HRS5965 tablets in Part 1, Part 2 and Part 3.
Study NCT05505955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subjects took Placebo in Part 1 and Part 2.
Study NCT05114421 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Given PO
Study NCT05114421 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT04868526 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: dietary intervention
Description: Research participants will be assigned to two dietary conditions.
Study NCT01419912 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: soy milk
Study NCT01419912 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: cow's milk
Study NCT06320769 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Plate Technique
Description: Using Plates, non-absorbable sutures or cerclage wires to guide the distal femoral physis towards rotational growth to correct deformity
Study NCT06275360 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Carboplatin, paclitaxel, and nivolumab for three cycles (for squamous cell lung cancer) or Carboplatin, pemetrexed, and nivolumab for three cycles (for lung adenocarcinoma) Followed by radiotherapy (60 Gy in 30 fractions) Followed by adjuvant nivolumab (six cycles)
Study NCT04990089 — intervention group
Intervention type: DEVICE
Intervention: VIVO
Description: VIVO is a per-procedural planning tool designed to non-invasively identify the origin of a ventricular arrhythmia.
Study NCT05009771 — intervention group
Intervention type: DRUG
Intervention: Intravenous patient-control analgesia
Description: At the two trial sites, IV-PCA is commonly used with morphine. The device is installed after delivery and removed within 3 days.
Study NCT05009771 — intervention group
Intervention type: DRUG
Intervention: Dinalbuphine sebacate
Description: Dinalbuphine sebacate is a prodrug of nalbuphine. With oil-based formulation, the active ingredient releases slowly and the effect lasts longer than nalbuphine. After delivery, a single 150 mg dose of dinalbuphine sebacate is administered intramuscularly.
Study NCT04640467 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Biophsical profile
Description: There are five components measured during the biophysical examination. A score of 2 points is given for each component that meets criteria. The test is continued until all criteria are met or 30 minutes have elapsed. The points are then added for a possible maximum score of 10. A total score of 10 out of 10 or 8 out of 10 with normal fluid is considered normal. A score of 6 is considered equivocal, and a score of 4 or less is abnormal.
Study NCT04640467 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cerebroplacental ratio
Description: CPR is the ratio of the Middle Cerebral Artery Pulsatility Index (MCA PI) to the Umbilical Artery Pulsatility Index (UA PI). The pulsatility indices will be measured from an automated trace of at least three consecutive waveforms of the relevant vessel in the absence of fetal breathing movements or uterine contractions. The angle of insonation will be as close to zero degrees as possible. The UA PI will be recorded from a free-floating section of cord, and the MCA PI will be obtained from the proximal third of the vessel (10, 14).
Study NCT06555549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DEH113
Description: tablets
Study NCT06555549 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: tablets
Study NCT05084911 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyramax
Description: Pyronaridine-Artesunate(180/60mg) tablet for 3days.
Study NCT05084911 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet for 3days.
Study NCT06156956 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation
Description: Fecal Microbiota Transplantation in capsules or suspension obtained from healthy unrelated donor introduced two times per treatment:~for capsules - FMT administration: day 7 (full dose) and days from 9 to 14 (prolonged intake regimen)~for suspension - FMT administration: day 7 and day 14
Study NCT06281860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatine Teva®
Description: PITHAC: Cisplatin (Cisplatine Teva®) at a dose between 7.5 and 70 mg/m2 of body surface at a temperature of 39±1°C
Study NCT04255446 — intervention group
Intervention type: DEVICE
Intervention: Thora3DiTM
Description: Not international
Study NCT04922476 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Alflorex®
Description: Each probiotic capsule contains 1 x 10\^9 CFU of B. longum 35624® and corn starch, hydroxypropyl methyl cellulose and magnesium stearate.
Study NCT05252364 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HP518 - Dose Escalation
Description: Part 1: Dose escalation~Daily oral dosage with the prescribed dose level based on Cohort assignment.
Study NCT05252364 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HP518 - Dose expansion
Description: Part 2: Dose expansion~Daily oral dosage with the highest dose with acceptable toxicity (RP2D) based on data from Part 1.
Study NCT05821803 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Using Insoles
Description: FootBalance %100 Control Orthopedic insoles used for 4 weeks.
Study NCT05821803 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Using Insoles
Description: FootBalance %100 Control Orthopedic insoles used for 4 weeks.
Study NCT05821803 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foot Core Exercises
Description: 4 weeks including
Study NCT05229302 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reframet IT
Description: The online intervention comprises 8 modules of cognitive behavioral therapy (CBT) delivered at schools by psychologists over 10 weeks. Contents: engagement and problem identification, emotional recognition and distress tolerance, identification of negative automatic thinking, help seeking and activity scheduling, problem solving, and cognitive restructuring, and a wrap up session. Two activities per module. Using a message board, the participant could communicate with research therapists who also check completed activities and respond with personalized messages. The face-to-face intervention comprises 4 CBT-based sessions to help the students in three aspects: i) close support and monitoring in case of an increase of symptomatology; ii) motivation to persist with the CBT; and iii) support the interaction between the students and CBT. Additionally, participants will be referred to a primary care clinic to receive treatment as usual.
Study NCT05229302 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Treatment as usual consists of identification and assisted referral to a primary care clinic where trained psychologists will assess the symptomatology and propose a course of actions, from initiation of psychotherapy to referral to a General practitioner to initiate medication if needed. Psychoterapy in primary care clinics consists of a range of 4-8 sessions twice a month. Most of the content of the psychotherapy are based on Cognitive-Behavioral Model. When needed, general practioners may suggest using medication, which normally are SSRI anditepressant (e.g., Fluoxetine, Sertraline). Medical check-up is conducted every month or every two months.
Study NCT05229302 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Treatment as usual consists of identification and assisted referral to a primary care clinic where trained psychologists will assess the symptomatology and propose a course of actions, from initiation of psychotherapy to referral to a General practitioner to initiate medication if needed. Psychoterapy in primary care clinics consists of a range of 4-8 sessions twice a month. Most of the content of the psychotherapy are based on Cognitive-Behavioral Model. When needed, general practioners may suggest using medication, which normally are SSRI anditepressant (e.g., Fluoxetine, Sertraline). Medical check-up is conducted every month or every two months.
Study NCT05810064 — intervention group
Intervention type: OTHER
Intervention: Falls-Risk Clinical Decision Support (CDS) Tool
Description: CDS in the Electronic Health Record (EHR) to screen patients at high-risk for future falls enabling referrals to the UW Health Mobility and Falls clinic.
Study NCT05909956 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KinesioTape
Description: The kinesio tape technique, one of the physiotherapy techniques, is an elastic thin band, water-resistant, air-permeable framework to stimulate muscle movements, assist weak muscles (fascia and soft tissue), reduce discomfort and muscle cramps, facilitate proprioceptive input, boost lymph and blood flow, and relieve pain. Participants in the KT group will receive therapeutic tape on the sacral and suprapubic regions with the Star shape and ligament technique (From initial 4 h to 72 h of the menstruation cycle)
Study NCT05909956 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Tape
Description: This group will receive KT tapping without stretch on the sacral and suprapubic region.
Study NCT05909956 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: General Physio session
Description: General physical therapy session including Hot pack (3-5min) and General body stretching(stretching of neck \& upper trapezius, arm \& shoulder girdle, triceps brachii, teres major \& minor, quadriceps muscle iliopsoas muscle, adductors muscle, hamstrings muscle) 30-45 sec each, for 7-10 min, (0-4 week) ,45-60sec each, for 10-15 min(4-8week), 15-20 min(8-12week) will be repeated 2 times/day.
Study NCT04268121 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neoadjuvant treatment
Description: 4 cycles of platinum-based chemotherapy (carboplatin or cisplatin) plus etoposide followed by surgery or chemoradiotherapy
Study NCT04268121 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adjuvant treatment
Description: Surgery (before study entry) followed by 4 cycles of platinum-based chemotherapy (carboplatin or cisplatin) plus etoposide
Study NCT04987333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavaleukin alfa
Description: Administered as a single dose SC injection.
Study NCT04930471 — intervention group
Intervention type: DRUG
Intervention: Metformin
Description: Treatment with Metformin as prescribed by the treating physician.
Study NCT04772274 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ustekinumab
Description: 45 mg, single-dose
Study NCT04772274 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ustekinumab
Description: 45 mg, single-dose
Study NCT04180293 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Pilot psychoeducation program
Description: Canadian Armed Forces veterans and their family members will be recruited to participate in this pilot virtual psychoeducation program and its evaluation. Two six-week sessions will be implemented over a virtual care platform (Zoom for healthcare) based out of OSI Clinic in Atlantic Canada - the first in January/February of 2021 and the second in the spring of 2021. A maximum of 10-15 participants (including both veterans and their family members) will be recruited for each group. Family members are defined as spouses/partners, siblings, parents, and adult children. Each of the weekly sessions will take place virtually and will be led by at least two trained facilitators (one from the research team, and one member of the OSI clinical staff team). Each of these sessions will focus on providing education of different topics relevant to those accessing services at the clinic (e.g., types of treatments available, tools to support families, self care, etc.).
Study NCT04180293 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Program evaluation
Description: At the end of each six-week session, program outcomes will be assessed qualitatively by a member of the research team. Participants will take part in semi-structured interviews guided by questions informed by the ecological family systems theory.
Study NCT04916509 — intervention group
Intervention type: DRUG
Intervention: Palbociclib plus an aromatase inhibitor
Description: Palbociclib plus an aromatase inhibitor therapy
Study NCT04636268 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FIB Grifols
Description: FIB Grifols is the IP and will be administered via slow intravenous (IV) infusion at a rate not to exceed 5 mL/minute.~Dosing will be individually calculated for each subject based on the target plasma fibrinogen level according to the type of bleeding, measured actual plasma fibrinogen level before infusion, and body weight. The IP will be administered according to the nominal potency of the product.
Study NCT06405191 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web based education
Description: The link to the web page was shared with the students in the experimental group (https://inonuhemsirelikesaslari.com, the expired page cannot be accessed at the moment). Theoretical training and application process steps video for IV catheterization and IM injection skills were taken to the students in the experimental group and uploaded to the web page. The students in the experimental group were given a username-password with which they could access the web page, and the access status of the students was followed by the researcher. The researcher was able to see the frequency of each student watching the videos and their scores in online tests. The student who did not watch the videos or did not take the test was interviewed and feedback was given about watching them. Students were able to access the web page as often as they wanted for two weeks.
Study NCT05279677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation plus Sintilimab and Fruquintinib
Description: Microbiota capsules containing 1g gut microbiota, po d1-3 before anti-tumor treatment, total for 8 cycles.~Sintilimab 200mg iv, q3w. Fruquintinib 5mg po d1-14, q3w.
Study NCT05623917 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tele-supervised diaphragmatic respiratory exercise
Description: the group will contain 20 females. the females will receive tele-supervised Diaphragmatic Respiratory Exercise ( applied at the homes of the females two times per the day, at the morning and at the evening, twenty minutes for every time, the sessions will be applied daily for 3 months in all females).
Study NCT06416384 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Hand Massage Group
Description: The patients in the hand massage application group were asked by the researcher; Hand massage with olive oil was applied 12 times in total, three times a week for four weeks. No application was made to the side with fistula.
Study NCT06416384 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: Patients in the control group received routine nursing care in the clinic for four weeks.
Study NCT05463484 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Test composition Saliactive® (olive product, betaine and xylitol)
Description: Fluoridated toothpaste with Saliactive®.
Study NCT05463484 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Fluoridated toothpaste without Saliactive®.
Study NCT05463484 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Commercial Fluoridated toothpaste for gingivitis with zinc citrate.
Study NCT04916509 — intervention group
Intervention type: DRUG
Intervention: Palbociclib plus fulvestrant
Description: Palbociclib plus fulvestrant
Study NCT04755634 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid
Description: Injectable
Study NCT05558280 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dinutuximab beta
Description: The study treatment will be administered with a continuous intravenous infusion at a dose of 14 mg/mq/day, days 1-5, a total of 60 hours (cumulative dose/cycle: 70 mg/mq). Each cycle lasts 28 days.The treatment phase foresees 5 cycles of Dinutuximab Beta.
Study NCT04841707 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: uEXPLORER/mCT
Description: Each participant will undergo two 18F-FDG PET/CT scans, one at baseline and one at 4- month (+/- 2 weeks) follow-up.
Study NCT04818684 — intervention group
Intervention type: OTHER
Intervention: questionnaire
Description: a questionnaire consisting of a list of support practices
Study NCT05348057 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivabradine
Description: The starting dose is 5 mg twice a day. Adjust the dose according to the actual situation
Study NCT05488587 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: magnesium and zinc levels
Description: measuring magnesium and zinc levels
Study NCT05261958 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SAQ training
Description: interventions listed above were applied on the players which will improve running mechanics and impove speed power and agility in football players
Study NCT05386992 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Anthropometric study
Description: Once the 5 models of lasts have been produced in phase 1, certain shoe models will be designed and manufactured based on these lasts at random and at the free choice of the designers of a footwear company. These models will then be physically tested on children to analyze their effects on walking and walking.
Study NCT06091215 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sciton Joule System
Description: Sciton Joule System
Study NCT05120479 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Kinesiotape
Description: Kinesiotape (KT): KT will be placed without any extra tension (in the scientific literature it is called paper off tension). The measure determined in the measurement with a tape measure is cut. The anchor of the KT is placed on the medial epicondyle with the body segments in a neutral position (anchor length: 5 cm). Placement of the active zone of the bandage with the flexor muscles of the fingers in elongation. Origin-insertion placement. Distal anchor in neutral position. Material: Kinesiotape: Kinesiology Tape TEMTEX ® Beige (Towatek Korea Co .; South Korea).
Study NCT05120479 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham tape
Description: Sham tape: exactly the same procedure is followed as above, but an adhesive inelastic tape is used. Material: Omnifix elastic (Laboratorios Hartmann S.A .; Spain).
Study NCT06022731 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Panoramic Radiography
Description: this retrospective study includes analysis of radiographs previously taken from patients for various purposes
Study NCT05745220 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Device: silicone hydrogel contact lens
Description: Silicone hydrogel contact lens